McNulty Christopher
Insider CIK 1701459 · NVIV Chief Financial Officer · VBIV CFO and Head of BD, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2022-01-27 | 2022-01-31 | 400,000 | — | $0 | 400,000 | SEC↗ |
| VBIV | A Award deriv | 2021-01-27 | 2021-01-29 | 500,000 | — | $0 | 500,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2020-07-01 | 2020-07-02 | 170,100 | — | $0 | 170,100 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2019-10-01 | 2019-10-01 | 12,000 | $0.47 | $5.6K | 37,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award | 2019-01-31 | 2019-02-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2018-09-19 | 2018-09-21 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2017-03-29 | 2017-03-31 | 29,973 | — | $0 | 29,973 | SEC↗ |